Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a high-risk pharmaceutical company based in China, specializing in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products. The company focuses on addressing cardiovascular and cerebrovascular diseases, respiratory diseases, tumors, diabetes, and related complications. With a Risk Rating Score of 36.1, Shijiazhuang Yiling Pharmaceutical Co., Ltd. offers a range of innovative drug series, chemical drugs, Chinese medicine series, and health products.